热门资讯> 正文
2025-05-13 04:34
Dianthus Therapeutics (NASDAQ: DNTH) reported quarterly losses of $(0.82) per share which beat the analyst consensus estimate of $(0.85) by 3.53 percent. This is a 51.85 percent decrease over losses of $(0.54) per share from the same period last year.